SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5szs'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EPB_A_9CRA165_1
(EPIDIDYMAL RETINOIC
ACID-BINDING PROTEIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 PHE A 402
ILE A 376
VAL A 373
LEU A 369
VAL A 404
None
1.03A 1epbA-5szsA:
undetectable
1epbA-5szsA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EPB_B_9CRB165_1
(EPIDIDYMAL RETINOIC
ACID-BINDING PROTEIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 PHE A 402
ILE A 376
VAL A 373
LEU A 369
VAL A 404
None
0.98A 1epbB-5szsA:
undetectable
1epbB-5szsA:
8.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GMK_C_DVAC6_0
(GRAMICIDIN A)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
3 / 3 ALA A  51
VAL A 182
TRP A  48
None
1.01A 1gmkC-5szsA:
undetectable
1gmkD-5szsA:
undetectable
1gmkC-5szsA:
1.75
1gmkD-5szsA:
1.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ASP A 393
HIS A 542
THR A 319
PRO A 536
GLY A 537
NAG  A1405 ( 4.8A)
None
None
None
None
1.42A 1ia0B-5szsA:
undetectable
1ia0B-5szsA:
16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IWH_A_PEMA501_1
(HEMOGLOBIN ALPHA
CHAIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 6 ALA A 810
LYS A 812
ASP A 816
ALA A 817
LEU A1078
None
1.11A 1iwhA-5szsA:
undetectable
1iwhA-5szsA:
7.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBH_A_SAMA293_1
(GLYCINE
N-METHYLTRANSFERASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
3 / 3 ARG A 530
ASP A 393
ASN A 240
None
NAG  A1405 ( 4.8A)
NAG  A1404 ( 1.8A)
0.91A 1nbhA-5szsA:
undetectable
1nbhA-5szsA:
13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NBH_D_SAMD3293_1
(GLYCINE
N-METHYLTRANSFERASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
3 / 3 ARG A 530
ASP A 393
ASN A 240
None
NAG  A1405 ( 4.8A)
NAG  A1404 ( 1.8A)
0.92A 1nbhD-5szsA:
undetectable
1nbhD-5szsA:
13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RA2_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ILE A 315
LEU A 266
PHE A 402
LEU A 300
ILE A 376
None
0.99A 1ra2A-5szsA:
undetectable
1ra2A-5szsA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RA8_A_FOLA161_0
(DIHYDROFOLATE
REDUCTASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ILE A 315
LEU A 266
PHE A 402
LEU A 300
ILE A 376
None
0.98A 1ra8A-5szsA:
undetectable
1ra8A-5szsA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TUB_B_TXLB501_1
(TUBULIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ASP A 393
HIS A 542
THR A 319
PRO A 536
GLY A 537
NAG  A1405 ( 4.8A)
None
None
None
None
1.42A 1tubB-5szsA:
undetectable
1tubB-5szsA:
15.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2GLU_B_SAMB302_0
(YCGJ)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 GLY A 594
ALA A 489
THR A 490
ALA A 491
ALA A 583
None
None
NAG  A1437 ( 4.0A)
None
None
1.01A 2gluB-5szsA:
undetectable
2gluB-5szsA:
9.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 5 PHE A 563
PHE A 554
PHE A 522
ILE A 507
None
1.24A 2v0mD-5szsA:
undetectable
2v0mD-5szsA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W98_B_P1ZB1358_1
(PROSTAGLANDIN
REDUCTASE 2)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 6 ASP A  67
TYR A 154
PHE A  64
LEU A  25
None
0.89A 2w98A-5szsA:
undetectable
2w98B-5szsA:
undetectable
2w98A-5szsA:
13.99
2w98B-5szsA:
13.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7W_C_SALC1300_1
(LYSR-TYPE REGULATORY
PROTEIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 7 THR A 930
ILE A 934
GLY A 931
PHE A 840
None
0.69A 2y7wC-5szsA:
undetectable
2y7wC-5szsA:
10.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AF0_A_PAUA314_0
(PANTOTHENATE KINASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 8 VAL A 186
LEU A  25
TYR A 204
HIS A 152
None
0.99A 3af0A-5szsA:
undetectable
3af0A-5szsA:
13.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CFL_A_5CHA693_1
(LACTOTRANSFERRIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 4 THR A 653
VAL A 474
GLY A 637
THR A 638
None
NAG  A1442 ( 4.3A)
None
None
1.09A 3cflA-5szsA:
undetectable
3cflA-5szsA:
13.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D4S_A_TIMA401_2
(BETA-2 ADRENERGIC
RECEPTOR/T4-LYSOZYME
CHIMERA)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
3 / 3 THR A 669
SER A 668
PHE A 664
NAG  A1442 ( 4.7A)
NAG  A1442 ( 3.4A)
None
0.90A 3d4sA-5szsA:
undetectable
3d4sA-5szsA:
16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GYQ_A_SAMA270_0
(RRNA
(ADENOSINE-2'-O-)-ME
THYLTRANSFERASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 LEU A 168
ALA A  76
GLY A  80
SER A 172
LEU A 171
None
1.23A 3gyqA-5szsA:
undetectable
3gyqB-5szsA:
undetectable
3gyqA-5szsA:
12.33
3gyqB-5szsA:
12.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KU1_H_SAMH226_0
(SAM-DEPENDENT
METHYLTRANSFERASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ARG A1176
GLY A1146
VAL A1197
GLY A1154
ILE A1192
None
None
NAG  A1472 ( 3.4A)
None
None
0.94A 3ku1H-5szsA:
undetectable
3ku1H-5szsA:
9.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LTW_A_HLZA300_1
(ARYLAMINE
N-ACETYLTRANSFERASE
NAT)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 6 PHE A 412
TYR A 298
VAL A 373
PHE A 402
None
1.26A 3ltwA-5szsA:
undetectable
3ltwA-5szsA:
11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MSS_B_STIB1_2
(TYROSINE-PROTEIN
KINASE ABL1)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 7 TYR A 960
VAL A1173
VAL A1177
ARG A1158
None
1.07A 3mssB-5szsA:
undetectable
3mssB-5szsA:
11.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_2
(FIV PROTEASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 9 ASP A 836
ALA A 839
ILE A 934
MET A 937
GLY A 940
None
1.02A 3ogpB-5szsA:
undetectable
3ogpB-5szsA:
6.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OWX_A_XRAA233_2
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 5 VAL A 273
ILE A 315
PHE A 326
PHE A 392
None
0.90A 3owxB-5szsA:
undetectable
3owxB-5szsA:
9.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3R_B_9PLB501_1
(CYTOCHROME P450 2A6)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 9 PHE A 402
PHE A 342
ILE A 340
GLY A 313
PHE A 412
None
1.40A 3t3rB-5szsA:
undetectable
3t3rB-5szsA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U7S_A_017A201_2
(POL POLYPROTEIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 9 ARG A1182
ALA A1143
GLY A1146
ILE A1147
LEU A1162
None
1.14A 3u7sB-5szsA:
undetectable
3u7sB-5szsA:
5.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1Y_A_RBFA1176_1
(PUTATIVE PROTEASE I)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 8 ASN A 510
LYS A 532
ASN A 506
THR A 490
NAG  A1434 ( 3.1A)
None
NAG  A1437 ( 1.8A)
NAG  A1437 ( 4.0A)
1.33A 4d1yA-5szsA:
undetectable
4d1yB-5szsA:
undetectable
4d1yA-5szsA:
8.68
4d1yB-5szsA:
8.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DF2_A_4CHA506_0
(NADPH DEHYDROGENASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 6 TYR A 544
HIS A 586
TYR A 587
TYR A 528
None
1.28A 4df2A-5szsA:
undetectable
4df2A-5szsA:
15.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJ1_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ILE A 315
LEU A 266
PHE A 402
LEU A 300
ILE A 376
None
0.97A 4ej1A-5szsA:
undetectable
4ej1A-5szsA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FHB_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ILE A 315
LEU A 266
PHE A 402
LEU A 300
ILE A 376
None
0.99A 4fhbA-5szsA:
undetectable
4fhbA-5szsA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I13_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ILE A 315
LEU A 266
PHE A 402
LEU A 300
ILE A 376
None
0.96A 4i13A-5szsA:
undetectable
4i13A-5szsA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LB2_A_DM5A602_1
(SERUM ALBUMIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 7 VAL A 505
ALA A 489
PHE A 487
TYR A 597
None
1.12A 4lb2A-5szsA:
undetectable
4lb2A-5szsA:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P3R_A_FOLA201_0
(DIHYDROFOLATE
REDUCTASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 ILE A 315
LEU A 266
PHE A 402
LEU A 300
ILE A 376
None
0.96A 4p3rA-5szsA:
undetectable
4p3rA-5szsA:
8.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4P6V_E_RBFE201_1
(NA(+)-TRANSLOCATING
NADH-QUINONE
REDUCTASE SUBUNIT B
NA(+)-TRANSLOCATING
NADH-QUINONE
REDUCTASE SUBUNIT E)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 5 HIS A1130
VAL A 775
GLU A 776
LYS A1094
None
1.32A 4p6vB-5szsA:
undetectable
4p6vE-5szsA:
0.8
4p6vB-5szsA:
14.90
4p6vE-5szsA:
9.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4S0V_A_SUVA2001_2
(HUMAN OREXIN
RECEPTOR TYPE 2
FUSION PROTEIN TO P.
ABYSII GLYCOGEN
SYNTHASE)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 5 ILE A 226
PRO A 227
HIS A 152
TYR A 161
None
1.25A 4s0vA-5szsA:
undetectable
4s0vA-5szsA:
18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCK_A_SAMA2409_0
(RNA-DIRECTED RNA
POLYMERASE L)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 12 GLU A 375
GLY A 388
TRP A 235
ALA A 379
THR A 381
None
None
None
None
NAG  A1405 ( 3.7A)
0.97A 4uckA-5szsA:
undetectable
4uckA-5szsA:
15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V32_A_EF2A151_1
(CEREBLON ISOFORM 4)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 7 ASN A 558
PRO A 610
PHE A 560
PHE A 563
None
1.28A 4v32A-5szsA:
undetectable
4v32A-5szsA:
6.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V32_B_EF2B151_1
(CEREBLON ISOFORM 4)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 7 ASN A 558
PRO A 610
PHE A 560
PHE A 563
None
1.33A 4v32B-5szsA:
undetectable
4v32B-5szsA:
6.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YV5_B_SVRB207_1
(BASIC PHOSPHOLIPASE
A2 HOMOLOG 2)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 6 LEU A 711
ASN A 713
PRO A 712
ARG A 746
None
1.38A 4yv5A-5szsA:
0.8
4yv5A-5szsA:
6.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F1A_B_SALB601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 7 LEU A 705
TYR A 703
GLY A 693
ALA A 685
None
0.87A 5f1aB-5szsA:
1.2
5f1aB-5szsA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5J4N_A_AG2A501_1
(ARGININE/AGMATINE
ANTIPORTER)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 6 SER A 772
GLY A1110
ASN A1111
ILE A1115
None
None
NAG  A1464 ( 1.8A)
None
1.13A 5j4nA-5szsA:
undetectable
5j4nA-5szsA:
16.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXD_A_ZITA501_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E MPHH)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 7 PHE A 734
ALA A 685
GLY A 457
TYR A 687
None
1.04A 5uxdA-5szsA:
undetectable
5uxdA-5szsA:
12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBP_D_DAHD123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 10 LEU A 151
THR A 159
ILE A 144
ILE A  89
ILE A 105
None
0.97A 6ebpD-5szsA:
undetectable
6ebpD-5szsA:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_A_DAHA123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 11 LEU A 151
THR A 159
ILE A 144
ILE A  89
ILE A 105
None
0.92A 6ebzA-5szsA:
undetectable
6ebzA-5szsA:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_B_DAHB123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 11 LEU A 151
THR A 159
ILE A 144
ILE A  89
ILE A 105
None
0.94A 6ebzB-5szsA:
undetectable
6ebzB-5szsA:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_C_DAHC123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 11 LEU A 151
THR A 159
ILE A 144
ILE A  89
ILE A 105
None
0.94A 6ebzC-5szsA:
undetectable
6ebzC-5szsA:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EBZ_D_DAHD123_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE,
BETA SUBUNIT)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 11 LEU A 151
THR A 159
ILE A 144
ILE A  89
ILE A 105
None
0.95A 6ebzD-5szsA:
undetectable
6ebzD-5szsA:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GP2_A_DAHA126_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
BETA CHAIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 11 LEU A 151
THR A 159
ILE A 144
ILE A  89
ILE A 105
None
1.00A 6gp2A-5szsA:
undetectable
6gp2A-5szsA:
4.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GP2_B_DAHB126_0
(RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE
BETA CHAIN)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
5 / 11 LEU A 151
THR A 159
ILE A 144
ILE A  89
ILE A 105
None
0.97A 6gp2B-5szsA:
undetectable
6gp2B-5szsA:
4.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6JI6_A_ACTA305_0
(GLUTATHIONE
S-TRANSFERASE
CLASS-MU 26 KDA
ISOZYME)
5szs SPIKE GLYCOPROTEIN
(Human
coronavirus
NL63)
4 / 5 GLY A  31
LEU A  30
SER A 219
GLN A 221
None
1.35A 6ji6A-5szsA:
undetectable
6ji6A-5szsA:
9.93